The study conducted by Western University of Health Sciences explores the adjunctive use of OMT to enhance the immune response to COVID-19 mRNA vaccination. Given the ongoing concerns regarding vaccine efficacy and the emergence of new variants, this research could position OMT as a complementary therapeutic approach in vaccination protocols. If successful, the findings may open avenues for partnerships with vaccine manufacturers and healthcare providers, potentially leading to new market opportunities in immunotherapy and preventive healthcare. The competitive landscape includes traditional vaccination strategies, and the results could influence clinical practice guidelines, enhancing the marketability of OMT within the osteopathic community and beyond.